Re-examining the role of benzodiazepines in the treatment of schizophrenia: A systematic review
Faye Sim, Isabel Sweetman, Shitij Kapur, Maxine X Patel
Journal of Psychopharmacology | SAGE PUBLICATIONS LTD | Published : 2015
Awarded by Medical Research Council
Awarded by National Institute for Health Research
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MXP holds a Clinician Scientist Award supported by the National Institute for Health Research and has also received consultancy fees, lecturing honoraria, and/or research funding from Janssen, Lilly, Endo, Lundbeck, Otsuka and Wyeth. MXP has previously or is currently working on clinical drug trials for Janssen and Amgen. SK has received grant support from AstraZeneca and GSK, and has served as consultant and/or speaker for AstraZeneca, Bioline, BMS-Otsuka, Lilly, Janssen, Lundbeck, NeuroSearch, Pfizer, Roche, Servier and Solvay Wyeth. FS and IS have no conflicts of interest to declare. The authors acknowledge support from the Department of Health via the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry at King's College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.